Each filer's latest filing for 639027101 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Prescott Group Capital Management, L.L.C.
13G/A
|
10.9% |
8/10/2026
Event 8/6/2026
|
||
| Prescott Group Capital Management, L.L.C. | 10.9% | |||
| Prescott Group Aggressive Small Cap LP | 10.9% | |||
| Prescott Group Aggressive Small Cap II LP | 10.9% | |||
| Prescott Group Aggressive Small Cap Master Fund GP | 10.9% | |||
| Frohlich Phil | 10.9% | |||
| Dimensional Fund Advisors LP 13G | 5.2% |
10/9/2025
Event 9/30/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
| BlackRock, Inc. 13G/A | 4.97% |
10/27/2026
Event 9/30/2026
|
||
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
13D/A
|
0.4% |
6/27/2025
Event 6/25/2025
|
||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 0.4% | |||
| Fosun Pharma USA Inc. | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 78 | 8.36 M | $106M |
| 2026 Q2 | 153 | 15.8 M | $344M |
| 2026 Q1 | 153 | 15.3 M | $367M |
| 2025 Q4 | 146 | 14.6 M | $316M |
| 2025 Q3 | 124 | 14.5 M | $225M |
| 2025 Q2 | 119 | 14.3 M | $211M |
| 2025 Q1 | 96 | 15.2 M | $191M |
| 2024 Q4 | 93 | 15.3 M | $224M |
| 2024 Q3 | 91 | 15.3 M | $209M |
| 2024 Q2 | 100 | 15.0 M | $226M |
| 2024 Q1 | 108 | 15.0 M | $311M |
| 2023 Q4 | 106 | 14.9 M | $258M |
| 2023 Q3 | 92 | 14.4 M | $237M |
| 2023 Q2 | 82 | 14.5 M | $198M |
| 2023 Q1 | 80 | 14.5 M | $138M |
| 2022 Q4 | 83 | 14.4 M | $120M |
| 2022 Q3 | 82 | 14.5 M | $119M |
| 2022 Q2 | 84 | 14.5 M | $155M |
| 2022 Q1 | 99 | 14.3 M | $241M |
| 2021 Q4 | 96 | 14.4 M | $267M |
| 2021 Q3 | 81 | 14.4 M | $211M |
| 2021 Q2 | 79 | 13.5 M | $235M |
| 2021 Q1 | 79 | 13.5 M | $317M |
| 2020 Q4 | 67 | 13.1 M | $196M |
| 2020 Q3 | 70 | 15.4 M | $178M |
| 2020 Q2 | 66 | 15.1 M | $136M |
| 2020 Q1 | 59 | 15.1 M | $123M |
| 2019 Q4 | 58 | 15.0 M | $134M |
| 2019 Q3 | 60 | 14.8 M | $123M |
| 2019 Q2 | 56 | 14.6 M | $136M |
| 2019 Q1 | 52 | 14.5 M | $135M |
| 2018 Q4 | 57 | 14.5 M | $119M |
| 2018 Q3 | 56 | 14.6 M | $127M |
| 2018 Q2 | 55 | 14.6 M | $136M |
| 2018 Q1 | 53 | 14.5 M | $160M |
| 2017 Q4 | 56 | 14.4 M | $167M |
| 2017 Q3 | 56 | 14.2 M | $144M |
| 2017 Q2 | 60 | 14.1 M | $187M |
| 2017 Q1 | 58 | 14.0 M | $140M |
| 2016 Q4 | 59 | 14.0 M | $210M |
| 2016 Q3 | 59 | 13.8 M | $222M |
| 2016 Q2 | 57 | 13.8 M | $131M |
| 2016 Q1 | 54 | 13.8 M | $132M |
| 2015 Q4 | 53 | 13.9 M | $141M |
| 2015 Q3 | 58 | 13.9 M | $168M |
| 2015 Q2 | 61 | 13.9 M | $191M |
| 2015 Q1 | 63 | 14.0 M | $184M |
| 2014 Q4 | 66 | 14.1 M | $208M |
| 2014 Q3 | 65 | 11.3 M | $167M |
| 2014 Q2 | 68 | 11.6 M | $196M |
| 2014 Q1 | 65 | 11.5 M | $159M |